Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-14 4:32 pm Sale | 13G | Kura Oncology Inc. KURA | BIOTECHNOLOGY VALUE FUND L P | 4,212,346 5.400% | -3,160,882 (-42.87%) | View |
| 2024-11-14 4:31 pm Purchase | 13G | Kura Oncology Inc. KURA | Paradigm Biocapital Advisors LP | 4,331,321 5.700% | 470,003 (+12.17%) | View |
| 2024-05-02 4:34 pm Purchase | 13G | Kura Oncology Inc. KURA | Paradigm Biocapital Advisors LP | 3,861,318 5.100% | 3,861,318 (New Position) | View |
| 2024-02-14 5:58 pm Purchase | 13G | Kura Oncology Inc. KURA | EcoR1 Capital LLC | 7,598,797 9.990% | 960,426 (+14.47%) | View |
| 2024-02-14 09:39 am Purchase | 13G | Kura Oncology Inc. KURA | BIOTECHNOLOGY VALUE FUND L P | 7,373,228 9.900% | 3,572,245 (+93.98%) | View |
| 2024-02-13 5:23 pm Purchase | 13G | Kura Oncology Inc. KURA | SUVRETTA CAPITAL MANAGEMENT LLC | 7,472,343 9.990% | 1,095,528 (+17.18%) | View |
| 2024-02-13 5:08 pm Purchase | 13G | Kura Oncology Inc. KURA | VANGUARD GROUP INC | 4,037,691 5.440% | 632,522 (+18.58%) | View |
| 2024-02-12 5:33 pm Purchase | 13G | Kura Oncology Inc. KURA | Flynn James E | 5,312,733 7.150% | 938,689 (+21.46%) | View |
| 2024-01-24 2:27 pm Purchase | 13G | Kura Oncology Inc. KURA | BlackRock Inc. BLK | 7,315,647 9.800% | 2,152,811 (+41.70%) | View |
| 2024-01-23 09:12 am Sale | 13G | Kura Oncology Inc. KURA | STATE STREET CORP STT | 2,921,810 3.930% | -1,524,617 (-34.29%) | View |
| 2023-09-21 4:55 pm Purchase | 13G | Kura Oncology Inc. KURA | Flynn James E | 4,374,044 5.890% | 1,991,044 (+83.55%) | View |
| 2023-02-14 09:32 am Sale | 13G | Kura Oncology Inc. KURA | Avoro Capital Advisors LLC | 3,105,000 4.500% | -895,000 (-22.38%) | View |
| 2023-02-14 08:44 am Sale | 13G | Kura Oncology Inc. KURA | Deep Track Capital LP | 0 0.000% | -3,362,000 (Position Closed) | View |
| 2023-02-13 6:17 pm Purchase | 13G | Kura Oncology Inc. KURA | BIOTECHNOLOGY VALUE FUND L P | 3,800,983 5.700% | 253,900 (+7.16%) | View |
| 2023-02-13 1:07 pm Purchase | 13G | Kura Oncology Inc. KURA | SUVRETTA CAPITAL MANAGEMENT LLC | 6,376,815 9.300% | 2,804,396 (+78.50%) | View |
| 2023-02-10 1:48 pm Purchase | 13G | Kura Oncology Inc. KURA | EcoR1 Capital LLC | 6,638,371 9.900% | 2,094,924 (+46.11%) | View |
| 2023-02-10 10:05 am Sale | 13G | Kura Oncology Inc. KURA | Flynn James E | 2,383,000 3.560% | -1,130,756 (-32.18%) | View |
| 2023-02-09 11:25 am Purchase | 13G | Kura Oncology Inc. KURA | VANGUARD GROUP INC | 3,405,169 5.090% | 3,405,169 (New Position) | View |
| 2023-02-03 12:15 pm Purchase | 13G | Kura Oncology Inc. KURA | STATE STREET CORP STT | 4,446,427 6.650% | 1,068,284 (+31.62%) | View |
| 2023-01-31 1:58 pm Purchase | 13G | Kura Oncology Inc. KURA | BlackRock Inc. BLK | 5,162,836 7.600% | 67,810 (+1.33%) | View |